Evolent Health, Inc. (EVH)
NYSE
Price as at 11 Aug 2026, 18:28 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Evolent Health, Inc. trades at USD4.07. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
9 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Glenn Welling, Engaged Capital LLC$30.16M · 9.2% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$27.68M · 0.0% of book
- Marshall Wace, MARSHALL WACE, LLP$18.50M · 0.0% of book
- Two Sigma, TWO SIGMA INVESTMENTS, LP$6.85M · 0.0% of book
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$4.30M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Common questions
Which funds own EVH?
9 of the institutions we track reported a position in EVH in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its EVH data?
Fundamentals for EVH come from company filings and exchange data, as listed on NYSE; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 11 Aug 2026, 18:28 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for EVH, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.